INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 125 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $328,000 | +29.1% | 58,906 | -9.0% | 0.00% | +100.0% |
Q2 2018 | $254,000 | -3.8% | 64,738 | +15.3% | 0.00% | -50.0% |
Q1 2018 | $264,000 | +34.0% | 56,126 | +17.4% | 0.00% | +100.0% |
Q4 2017 | $197,000 | -27.3% | 47,812 | +11.7% | 0.00% | -50.0% |
Q3 2017 | $271,000 | +14.3% | 42,820 | +41.6% | 0.00% | +100.0% |
Q2 2017 | $237,000 | +18.5% | 30,242 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $200,000 | -4.8% | 30,242 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $210,000 | -20.5% | 30,242 | +6.9% | 0.00% | -50.0% |
Q3 2016 | $264,000 | +9.1% | 28,292 | +8.0% | 0.00% | 0.0% |
Q2 2016 | $242,000 | +6.1% | 26,195 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $228,000 | +5.1% | 26,195 | -18.8% | 0.00% | +100.0% |
Q4 2015 | $217,000 | +61.9% | 32,275 | +38.7% | 0.00% | 0.0% |
Q3 2015 | $134,000 | -29.5% | 23,263 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $190,000 | 0.0% | 23,263 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $190,000 | +13.8% | 23,263 | +27.9% | 0.00% | 0.0% |
Q4 2014 | $167,000 | – | 18,183 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 648,800 | $1,920,000 | 1.55% |
Round Table Services, LLC | 339,391 | $998,000 | 0.31% |
ARK Investment Management | 3,955,017 | $11,628,000 | 0.29% |
Nikko Asset Management Americas, Inc. | 4,884,100 | $14,359,000 | 0.28% |
WASATCH ADVISORS LP | 6,735,726 | $19,803,000 | 0.19% |
Cedar Brook Financial Partners, LLC | 41,500 | $122,000 | 0.06% |
Unified Trust Company, N.A. | 15,716 | $46,000 | 0.03% |
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 13,500 | $40,000 | 0.03% |
STONERIDGE INVESTMENT PARTNERS LLC | 16,914 | $50,000 | 0.02% |
Sumitomo Mitsui Trust Holdings, Inc. | 4,884,100 | $14,359,000 | 0.01% |